4.7 Article

The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ

Related references

Note: Only part of the references are listed.
Article Oncology

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage

Lauren C. Peres et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Oncology

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage

Lauren C. Peres et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Biochemistry & Molecular Biology

Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells

Lei Zhang et al.

ONCOGENE (2019)

Article Cell Biology

Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma

Afak Rasheed Salman Zaidi et al.

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2019)

Review Oncology

The disparate origins of ovarian cancers: pathogenesis and prevention strategies

Anthony N. Karnezis et al.

NATURE REVIEWS CANCER (2017)

Article Biochemistry & Molecular Biology

Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein

M. R. Tanas et al.

ONCOGENE (2016)

Article Oncology

A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer

Fernando J. de Miguel et al.

MOLECULAR ONCOLOGY (2016)

Review Oncology

The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer

Seiji Mabuchi et al.

GYNECOLOGIC ONCOLOGY (2015)

Article Multidisciplinary Sciences

The RNA-binding proteomes from yeast to man harbour conserved enigmRBPs

Benedikt M. Beckmann et al.

NATURE COMMUNICATIONS (2015)

Article Oncology

An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non-Small Cell Lung Cancer

Satoshi Noguchi et al.

CLINICAL CANCER RESEARCH (2014)

Review Genetics & Heredity

A census of human RNA-binding proteins

Stefanie Gerstberger et al.

NATURE REVIEWS GENETICS (2014)

Article Genetics & Heredity

The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing

Feng-Yang Zong et al.

PLOS GENETICS (2014)

Review Cell Biology

The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway

Wanjin Hong et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)

Article Biochemistry & Molecular Biology

QKI-Mediated Alternative Splicing of the Histone Variant MacroH2A1 Regulates Cancer Cell Proliferation

Leonid Novikov et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Article Biochemistry & Molecular Biology

The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene

X. Zhang et al.

ONCOGENE (2011)

Article Multidisciplinary Sciences

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

Li Lu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition

Heng Zhang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

The selective RNA-binding protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation

Yuntao Chen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Target RNA motif and target mRNAs of the Quaking STAR protein

A Galarneau et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)